Brief Reports
Copyright ©The Author(s) 2000.
World J Gastroenterol. Oct 15, 2000; 6(5): 747-749
Published online Oct 15, 2000. doi: 10.3748/wjg.v6.i5.747
Table 1 Inhibitory effects of liposome-ODN
Group48 h
72 h
MTT value (x-± s)Inhibition rate (%)MTT value (x-± s)Inhibition rate (%)
Control0.445 ± 0.0160.337 ± 0.003
Liposome-RC150.389 ± 0.01512.60.091 ± 0.00812.2
Liposome-AEGFR0.078 ± 0.02282.50.079 ± 0.00576.6
Table 2 Cell cycle assay
GroupG0/G2 (%)S (%)G2 + M (%)PI
Control21.659.918.50.784
Liposome-RC1529.554.915.60.705
Liposome-AEGFR57.132.510.10.329
Table 3 Inhibition of subcutaneous HR8348 adenocarcinoma growth by ASODN
GroupDiameter of tumor (cm)Rate of tumorigenicity (%)
Control1.00 ± 0.08100 (10/10)
Liposome-RC150.95 ± 0.07100 (10/10)
Liposome-AEGFR0.8020 (2/10)